AbbVie
ABBV
#31
Rank
โ‚น41.922 T
Marketcap
โ‚น23,724
Share price
-0.53%
Change (1 day)
36.57%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): โ‚น533.26 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น62.81 Billion. In 2025 the company made an earning of โ‚น629.13 Billion, an increase over its 2024 earnings that were of โ‚น354.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น533.26 B-15.24%
2025 โ‚น629.13 B77.53%
2024 โ‚น354.38 B-40.54%
2023 โ‚น596.04 B-53.62%
2022 โ‚น1.285 T3.76%
2021 โ‚น1.238 T282.25%
2020 โ‚น324.05 B-59.67%
2019 โ‚น803.56 B62.13%
2018 โ‚น495.62 B-32.74%
2017 โ‚น736.90 B-1.99%
2016 โ‚น751.87 B18.65%
2015 โ‚น633.71 B180.5%
2014 โ‚น225.92 B-55.57%
2013 โ‚น508.49 B-6.86%
2012 โ‚น545.97 B56.05%
2011 โ‚น349.85 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.010 T 77.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.968 T 420.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น866.60 B 52.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น154.78 B-72.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น1.023 T 79.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น915.24 B 60.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.398 T 145.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น954.76 B 67.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น76.17 B-86.63%๐Ÿ‡บ๐Ÿ‡ธ USA